Akèy › Fibroz Pulmonè Idyopatik › Kalifòni
Etid klinik pou Fibroz Pulmonè Idyopatik nan Kalifòni
13 etid pou Fibroz Pulmonè Idyopatik ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
- University of California, San Francisco, San Francisco
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07673237An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- University of Southern California, Los Angeles
- Newport Native MD, Inc., Newport Beach
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Loma Linda
- Research Site, Los Angeles
- Research Site, Newport Beach
- ak 2 plis
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Newportnativemd, Inc., Newport Beach
- Palmtree Clinical Research, Palm Springs
- Paradigm Clinical Research Centers, Inc. - Redding, Redding
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Southern California, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
- Paradigm Clinical Research Centers, LLC, San Diego
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Palmtree Clinical Research Inc., Palm Spring
- Paradigm Clinical Research Centers LLC, Redding
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284602Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- University of California San Francisco, San Francisco
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
- Stanford University, Stanford
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511Dose-Escalation Study of Artesunate Patients With IPF
- Stanford University, Stanford
Ap rekriteFaz 1
Laj 40 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05988463WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Los Angeles, CA, Los Angeles
- WISPer site in Newport Beach, CA, Newport Beach
- WISPer Site in Palm Springs, CA, Palm Springs
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06967805Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Keck School of Medicine of USC, Los Angeles
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
- Cedars-Sinai, Los Angeles
Ap rekriteFaz 2
Laj 50 ak plis · Tout sèks · Mizajou Nov 10, 2025 · NCT06567717Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.